5-HT2 and 5-HT3 serotonin receptors and alpha-1 adrenergic receptors (5-HT2/5-HT3/alpha-1AR)

The 5-HT2 and 5-HT3 serotonin receptors and alpha-1 adrenergic receptors represent a cluster of distinct molecular targets often modulated simultaneously by psychotropic medications. The 5-HT2 family (including 5-HT2A, 2B, and 2C) consists of G protein-coupled receptors (GPCRs) that influence mood, anxiety, and sleep, with 5-HT2A being a primary target for atypical antipsychotics to reduce extrapyramidal symptoms (UniProt P28223). The 5-HT3 receptor is unique among serotonin receptors as a ligand-gated ion channel that mediates fast excitatory neurotransmission and is a key player in the emetic reflex (UniProt P46098). Alpha-1 adrenergic receptors (alpha-1A, 1B, and 1D) are GPCRs that mediate the action of norepinephrine on smooth muscle, particularly in the cardiovascular system (UniProt P35348). Drugs such as clozapine, mirtazapine, and quetiapine exhibit varying affinities for these receptors, utilizing 5-HT2 and 5-HT3 antagonism to improve therapeutic outcomes in schizophrenia and depression while often incurring alpha-1-mediated side effects like orthostatic hypotension (PubChem CID 2722, 4205). This multi-target profile is essential for the efficacy of many second-generation antipsychotics but requires careful management of cardiovascular and metabolic safety.

Other names

Serotonin 2 and 3 receptors and alpha-1 adrenoceptors5-HT2, 5-HT3, and alpha-1 receptor complex5-HT2/3/alpha-1 adrenergic receptor group

Antagonism of 5-HT2 and 5-HT3 serotonin receptors and alpha-1 adrenergic receptors to modulate monoaminergic signaling and reduce psychotic or depressive symptoms.